Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Leap Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
LPTX
Nasdaq
8731
https://www.leaptx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Leap Therapeutics Inc
Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
- Mar 20th, 2024 1:35 pm
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 18th, 2024 11:00 am
Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
- Jan 16th, 2024 10:05 pm
Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 12:00 pm
Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients
- Jan 2nd, 2024 12:00 pm
Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium
- Dec 11th, 2023 9:05 pm
Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference
- Nov 21st, 2023 12:00 pm
Leap Therapeutics Reports Third Quarter 2023 Financial Results
- Nov 13th, 2023 12:00 pm
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
- Oct 24th, 2023 4:30 pm
These 2 “Strong Buy” Penny Stocks Could Gain Over 500%, Says Baird
- Oct 3rd, 2023 1:55 pm
Leap Therapeutics to Participate at Upcoming Investor Conferences
- Sep 5th, 2023 11:00 am
Leap Therapeutics Reports Second Quarter 2023 Financial Results
- Aug 14th, 2023 11:00 am
10 Most Promising Penny Stocks According to Analysts
- Aug 13th, 2023 2:44 pm
Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients
- Jul 12th, 2023 11:00 am
Leap Therapeutics Announces Reverse Stock Split
- Jun 20th, 2023 4:30 pm
10 Hot Penny Stocks To Buy
- Jun 4th, 2023 11:11 am
Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting
- May 25th, 2023 9:10 pm
Leap Therapeutics Reports First Quarter 2023 Financial Results
- May 15th, 2023 11:00 am
Leap Therapeutics Announces Completion of Enrollment in Part A of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer Patients
- Apr 12th, 2023 11:00 am
Leap Therapeutics (NASDAQ:LPTX) Will Have To Spend Its Cash Wisely
- Apr 4th, 2023 3:10 pm
Scroll